Skip to main content

Skadden, Arps, Slate, Meagher & Flom has advised Japan’s Nippon Shokubai on its acquisition of Sirrus, a U.S.-based chemical company, which was represented by Cooley. The financial terms of the transaction were not disclosed. 

Founded as Bioformix in 2009, Sirrus has built a portfolio of more than 25 global patents that address process technologies, methods of application, initiation, formulation and stabilisation, as well as composition of matter for certain polymers. 

“Combined with Sirrus’ intellectual property position, track record of innovation, and access to a broad range of customers and applications, the transaction is a strong strategic fit for Nippon Shokubai,” said Masanori Ikeda, the Japanese chemical giant’s president, in a statement.  

The Skadden team was led by partners Mitsuhiro Kamiya, Michael Mies and Resa Schlossberg.

Related Articles

Deals

Khaitan, JSA, Hogan Lovells guide $515 mln Waaree IPO

by Nimitt Dixit |

Khaitan & Co has advised Waaree Energies, India's largest manufacturer and exporter of solar modules, on its $515 million initial public offering, with JSA Advocates & Solicitors and Hogan Lovells guiding the bookrunning lead managers.

Deals

CAM, Khaitan guide Adani-backed Renew Exim’s $380 mln ITD acquisition

by Nimitt Dixit |

Cyril Amarchand Mangaldas has advised Adani Group's Dubai-based firm Renew Exim DMCC on its acquisition of a 46.64 percent stake in ITD Cementation India for around $380 million from Italian-Thai Development Public Company, who was represented by Khaitan & Co.

Deals

CAM, AZB, SAM, Latham advise on landmark $1.3 bln Swiggy IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas is advising SoftBank-backed Indian food and grocery delivery giant Swiggy on its much-anticipated initial public offering worth $1.3 billion, with AZB & Partners and Latham & Watkins advising the bookrunning lead managers.